Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,689 across all filing types
Latest filing 2020-04-22 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
关于全资子公司与厦门致善生物科技股份有限公司日常关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a related party transaction between the company's wholly owned subsidiary and another company. It details the nature of the transaction, pricing principles, amounts involved, and independent director opinions. It does not contain financial statements or comprehensive financial data, nor is it a report or presentation. It is a regulatory announcement about a specific corporate transaction, fitting the category of Regulatory Filings (RNS) as it does not fit other more specific categories like Annual Report, Interim Report, or Capital/Financing Update.
2020-04-22 Chinese
关于举行2019年年度报告网上业绩说明会的公告
AGM Information Classification · 95% confidence The document is an announcement about holding an online performance explanation meeting related to the 2019 Annual Report. It states that the 2019 Annual Report and its summary were disclosed on April 23, 2020, and the meeting is scheduled for April 28, 2020. The document does not contain the actual annual report or detailed financial data but rather invites investors to participate in a webcast to discuss the report. The document length is short (579 characters), and it serves as a notice for an event related to the annual report rather than the report itself. According to the 'Menu vs Meal' rule, this is an announcement about a report-related event, fitting the category of AGM Information (AGM-R) or possibly an Investor Presentation (IP). However, since it is specifically about an annual report performance explanation meeting (业绩说明会), which is typically considered an AGM-related presentation, the best fit is AGM Information (AGM-R).
2020-04-22 Chinese
第四届监事会第四次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of the company regarding the review and approval of various reports and proposals including the 2019 Annual Report, 2019 Financial Statements, 2019 Profit Distribution Plan, Internal Control Self-Evaluation Report, and the 2020 First Quarter Report. The document does not contain the full reports themselves but rather the resolutions approving these reports and mentions that the full reports are available on an external website (cninfo.com.cn). The document is relatively short (2664 characters) and serves as an official announcement of the Supervisory Board's meeting decisions and approvals, not the reports themselves. Therefore, it fits best as a Regulatory Filing (RNS) since it is an official announcement related to regulatory compliance and approvals but does not contain the full financial reports or detailed financial data itself.
2020-04-22 Chinese
非经营性资金占用及其他关联资金往来情况汇总表的专项审核报告
Audit Report / Information Classification · 95% confidence The document is a specialized audit report issued by Zhongxinghua Certified Public Accountants LLP regarding the 2019 non-operating fund occupation and other related party fund transactions of Dirui Medical Technology Co., Ltd. It includes detailed audit procedures, references to Chinese regulatory requirements, and a summary table of related party transactions. The document is titled as a '专项审核报告' (special audit report) and contains audit opinions and supporting schedules. It is not a full annual report (10-K), nor a general audit report of financial statements (AR), but a standalone audit report focused on a specific issue related to related party transactions and non-operating fund occupation. The document length is 3444 characters, which is consistent with a standalone audit report rather than a full annual report or interim report. Therefore, the most appropriate classification is Audit Report / Information (AR). FY 2019
2020-04-22 Chinese
2020年第一季度报告披露提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (317 characters) indicating that the full 2020 first quarter report has been published on the official disclosure website. It does not contain the actual financial data or substantive analysis itself, but rather directs investors to the full report. According to the 'MENU VS MEAL' rule, such a brief notice that a report is available elsewhere is classified as a Report Publication Announcement (RPA).
2020-04-22 Chinese
关于公司获得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of medical device registration certificates issued by the National Medical Products Administration. It details the product names, registration numbers, validity periods, and clinical uses. The document is a formal disclosure to inform shareholders and the public about regulatory approvals obtained by the company. It does not contain financial statements, management discussion, or detailed financial data. It is not a report like an Annual Report, Interim Report, or Earnings Release. It is also not a regulatory certification or officer attestation. The document is an official announcement of a regulatory milestone relevant to the company's product approvals. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-04-20 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.